Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
TechCrunch · Wed, 23 Sep 2026 19:31:28 GMT
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.